![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
NT5E - Wikipedia
NT5E (CD73) is a surface enzyme which is expressed on multiple cells. This enzyme mediates the gradual hydrolysis of the autocrine and paracrine danger signals of ATP and ADP to anti-inflammatory adenosine. Immune suppression mediated by adenosinergic pathways is very important for maintaining immune system homeostasis.
CD73: an emerging checkpoint for cancer immunotherapy - PMC
CD73 is a novel immune checkpoint associated with adenosine metabolism that promotes tumor progression by suppressing antitumor immune response and promoting angiogenesis.
CD73: an emerging checkpoint for cancer immunotherapy
CD73 is a novel immune checkpoint associated with adenosine metabolism that promotes tumor progression by suppressing antitumor immune response and promoting angiogenesis.
The Clinical Significance of CD73 in Cancer - PMC - PubMed …
CD73, mainly by the production of adenosine, is critical in the suppression of an adequate anti-tumour immune response, but also in promoting cancer cell proliferation, tumour growth, angiogenesis, and metastasis.
CD73, Tumor Plasticity and Immune Evasion in Solid Cancers
Accumulating data suggest that solid tumors hijack cellular plasticity possibly to evade detection by the immune system. CD73-mediated generation of the purine nucleoside adenosine, is an important biochemical constituent of the immunosuppressive tumor microenvironment.
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor
2023年1月6日 · Here, we report that elevation of CD73 levels due to its aberrant turnover is correlated with poor prognosis in immune-cold triple-negative breast cancers (TNBCs). We have identified TRIM21 as an E3 ligase that governs CD73 destruction.
The Clinical Significance of CD73 in Cancer - PubMed
2023年7月21日 · CD73, mainly by the production of adenosine, is critical in the suppression of an adequate anti-tumour immune response, but also in promoting cancer cell proliferation, tumour growth, angiogenesis, and metastasis.
The cell-surface 5′-nucleotidase CD73 defines a ... - Cell Press
2021年11月9日 · We identified CD73 as a molecule that allowed a hereto-unknown subsetting of memory CD4 and CD8 T cells that does not correlate with previously defined subsets, is functionally meaningful, and changes with age.
CD39/CD73/A2AR pathway and cancer immunotherapy
The CD39 /CD73/A2AR signaling pathway has been shown to be associated with poor cancer prognosis. In addition, CD39 and CD73 are also involved in the formation of new lymphatic vessels around tumors and progression of malignant tumors such as breast carcinoma, multiforme glioblastoma and chronic lymphocytic leukemia [78,79,80].
Targeting CD73 to augment cancer immunotherapy - PubMed
CD73 (ecto-5'-nucleotidase) is a novel immunoinhibitory protein that plays a key role for tumor growth and metastasis. Its main function is to convert extracellular ATP to immunosuppressive adenosine in concert with CD39 in normal tissues to limit excessive immune response.